Table 3.
Birth country | Thalassemia |
Sickle cell anemia |
||||||
---|---|---|---|---|---|---|---|---|
O | IR | 95% CI | O | IR | 95% CI | |||
Sweden | 1121 | 0.7 | 0.6 | 0.7 | 346 | 0.2 | 0.1 | 0.3 |
Other European countries | 205 | 1.5 | 1.3 | 1.6 | 33 | 0.2 | 0.0 | 0.5 |
Greece | 46 | 14.3 | 14.0 | 14.6 | 1 | 0.2 | 0.0 | 2.1 |
Africa | 105 | 9.8 | 9.7 | 10.0 | 128 | 10.9 | 10.8 | 11.1 |
North Africa | 33 | 14.3 | 14.0 | 14.7 | 2 | 1.3 | 0.0 | 2.6 |
Sub-Saharan Africa | 72 | 8.7 | 8.4 | 8.9 | 126 | 13.0 | 12.8 | 13.2 |
North America | 7 | 1.8 | 1.0 | 2.5 | 5 | 2.3 | 1.4 | 3.2 |
Latin America | 24 | 2.0 | 1.6 | 2.4 | 5 | 0.3 | 0.0 | 1.2 |
Asia | 1578 | 27.3 | 27.2 | 27.3 | 57 | 1.1 | 0.8 | 1.4 |
Turkey | 67 | 7.6 | 7.4 | 7.8 | 3 | 0.9 | 0.0 | 2.0 |
Lebanon | 75 | 16.4 | 16.2 | 16.6 | 13 | 2.0 | 1.5 | 2.6 |
Iran | 286 | 25.7 | 25.6 | 25.9 | 5 | 0.3 | 0.0 | 1.2 |
Iraq | 537 | 47.1 | 47.0 | 47.2 | 22 | 2.2 | 1.8 | 2.6 |
Syria | 68 | 20.5 | 20.3 | 20.7 | 2 | 3.6 | 2.2 | 5.0 |
Other Arabic countries | 50 | 40.6 | 40.4 | 40.9 | 3 | 3.6 | 2.5 | 4.7 |
Afghanistan | 38 | 30.2 | 29.8 | 30.5 | 1 | 1.2 | 0.0 | 3.1 |
Bangladesh | 16 | 14.1 | 13.6 | 14.6 | 0 | |||
Pakistan | 18 | 28.5 | 28.0 | 28.9 | 2 | 2.1 | 0.7 | 3.4 |
India | 72 | 28.3 | 28.0 | 28.5 | 4 | 1.5 | 0.5 | 2.4 |
China | 34 | 14.8 | 14.5 | 15.2 | 0 | |||
Thailand | 212 | 62.9 | 62.7 | 63.0 | 1 | 0.6 | 0.0 | 2.6 |
Vietnam | 36 | 13.7 | 13.4 | 14.0 | 0 | |||
Philippines | 16 | 27.8 | 27.4 | 28.3 | 0 | |||
Russia | 18 | 4.9 | 4.4 | 5.4 | 1 | 0.2 | 0.0 | 2.2 |
Others | 6 | 1.8 | 1.0 | 2.6 | 9 | 3.4 | 2.7 | 4.0 |
All | 3064 | 1.5 | 1.5 | 1.6 | 584 | 0.3 | 0.2 | 0.3 |
O: observed number of cases; IR: incidence rate per 100,000 person years, adjusted for the European Standard Population for 2000; CI: confidence interval.